These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 9635697

  • 1. The treatment of nonpalpable PSA-detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy.
    Horwitz EM, Hanlon AL, Pinover WH, Hanks GE.
    Int J Radiat Oncol Biol Phys; 1998 Jun 01; 41(3):519-23. PubMed ID: 9635697
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dose response in prostate cancer with 8-12 years' follow-up.
    Hanks GE, Hanlon AL, Epstein B, Horwitz EM.
    Int J Radiat Oncol Biol Phys; 2002 Oct 01; 54(2):427-35. PubMed ID: 12243818
    [Abstract] [Full Text] [Related]

  • 4. Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy.
    Anderson PR, Hanlon AL, Patchefsky A, Al-Saleem T, Hanks GE.
    Int J Radiat Oncol Biol Phys; 1998 Jul 15; 41(5):1087-92. PubMed ID: 9719119
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control.
    Kaminski JM, Hanlon AL, Horwitz EM, Pinover WH, Mitra RK, Hanks GE.
    Int J Radiat Oncol Biol Phys; 2002 Mar 15; 52(4):888-92. PubMed ID: 11958880
    [Abstract] [Full Text] [Related]

  • 9. Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques.
    Horwitz EM, Hanlon AL, Pinover WH, Anderson PR, Hanks GE.
    Cancer; 2001 Sep 01; 92(5):1281-7. PubMed ID: 11571744
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Optimization of conformal radiation treatment of prostate cancer: report of a dose escalation study.
    Hanks GE, Schultheiss TE, Hanlon AL, Hunt M, Lee WR, Epstein BE, Coia LR.
    Int J Radiat Oncol Biol Phys; 1997 Feb 01; 37(3):543-50. PubMed ID: 9112451
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy.
    Iyer RV, Hanlon AL, Pinover WH, Hanks GE.
    Cancer; 1999 Apr 15; 85(8):1816-21. PubMed ID: 10223577
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer.
    Galalae RM, Kovács G, Schultze J, Loch T, Rzehak P, Wilhelm R, Bertermann H, Buschbeck B, Kohr P, Kimmig B.
    Int J Radiat Oncol Biol Phys; 2002 Jan 01; 52(1):81-90. PubMed ID: 11777625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.